Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors.
Kufareva I, Bestgen B, Brear P, Prudent R, Laudet B, Moucadel V, Ettaoussi M, Sautel CF, Krimm I, Engel M, Filhol O, Borgne ML, Lomberget T, Cochet C, Abagyan R.
Kufareva I, et al. Among authors: brear p.
Sci Rep. 2019 Nov 4;9(1):15893. doi: 10.1038/s41598-019-52141-5.
Sci Rep. 2019.
PMID: 31685885
Free PMC article.